Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications
{{output}}
Tumor derived biomarkers including circulating tumor DNA (ctDNA) and/or circulating tumors cells (CTCs) may be detected and quantified through liquid biopsy (LB). ctDNA analysis through LB is a validated tool for monitoring response to systemic treatment and d... ...
